全文获取类型
收费全文 | 1085篇 |
免费 | 81篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 37篇 |
妇产科学 | 11篇 |
基础医学 | 113篇 |
口腔科学 | 17篇 |
临床医学 | 122篇 |
内科学 | 182篇 |
皮肤病学 | 347篇 |
神经病学 | 28篇 |
特种医学 | 45篇 |
外科学 | 127篇 |
综合类 | 9篇 |
预防医学 | 30篇 |
眼科学 | 14篇 |
药学 | 36篇 |
肿瘤学 | 52篇 |
出版年
2022年 | 6篇 |
2021年 | 10篇 |
2020年 | 10篇 |
2019年 | 15篇 |
2018年 | 15篇 |
2017年 | 17篇 |
2016年 | 19篇 |
2015年 | 28篇 |
2014年 | 31篇 |
2013年 | 22篇 |
2012年 | 60篇 |
2011年 | 54篇 |
2010年 | 33篇 |
2009年 | 47篇 |
2008年 | 46篇 |
2007年 | 51篇 |
2006年 | 70篇 |
2005年 | 34篇 |
2004年 | 46篇 |
2003年 | 42篇 |
2002年 | 37篇 |
2001年 | 41篇 |
2000年 | 34篇 |
1999年 | 34篇 |
1998年 | 28篇 |
1997年 | 30篇 |
1996年 | 28篇 |
1995年 | 18篇 |
1994年 | 22篇 |
1993年 | 17篇 |
1992年 | 27篇 |
1991年 | 12篇 |
1990年 | 14篇 |
1989年 | 5篇 |
1988年 | 17篇 |
1987年 | 14篇 |
1986年 | 13篇 |
1985年 | 17篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1982年 | 9篇 |
1981年 | 12篇 |
1979年 | 8篇 |
1978年 | 6篇 |
1976年 | 4篇 |
1973年 | 4篇 |
1972年 | 5篇 |
1971年 | 6篇 |
1925年 | 3篇 |
1921年 | 3篇 |
排序方式: 共有1173条查询结果,搜索用时 15 毫秒
1.
Rob NM Weijers 《World journal of diabetes》2020,11(5):165-181
ResearchGate is a world wide web for scientists and researchers to share papers, ask and answer questions, and find collaborators. As one of the more than 15 million members, the author uploads research output and reads and responds to some of the questions raised, which are related to type 2 diabetes. In that way, he noticed a serious gap of knowledge of this disease among medical professionals over recent decades. The main aim of the current study is to remedy this situation through providing a comprehensive review on recent developments in biochemistry and molecular biology, which can be helpful for the scientific understanding of the molecular nature of type 2 diabetes. To fill up the shortcomings in the curricula of medical education, and to familiarize the medical community with a new concept of the onset of type 2 diabetes, items are discussed like: Insulin resistance, glucose effectiveness, insulin sensitivity, cell membranes, membrane flexibility, unsaturation index (UI; number of carbon-carbon double bonds per 100 acyl chains of membrane phospholipids), slow-down principle, effects of temperature acclimation on phospholipid membrane composition, free fatty acids, energy transport, onset of type 2 diabetes, metformin, and exercise. Based on the reviewed data, a new model is presented with proposed steps in the development of type 2 diabetes, a disease arising as a result of a hypothetical hereditary anomaly, which causes hyperthermia in and around the mitochondria. Hyperthermia is counterbalanced by the slow-down principle, which lowers the amount of carbon-carbon double bonds of membrane phospholipid acyl chains. The accompanying reduction in the UI lowers membrane flexibility, promotes a redistribution of the lateral pressure in cell membranes, and thereby reduces the glucose transporter protein pore diameter of the transmembrane glucose transport channel of all Class I GLUT proteins. These events will set up a reduction in transmembrane glucose transport. So, a new blood glucose regulation system, effective in type 2 diabetes and its prediabetic phase, is based on variations in the acyl composition of phospholipids and operates independent of changes in insulin and glucose concentration. UI assessment is currently arising as a promising analytical technology for a membrane flexibility analysis. An increase in mitochondrial heat production plays a pivotal role in the existence of this regulation system. 相似文献
2.
3.
4.
5.
Thomas A. Luger Harald Gollnick Thomas Schwennesen Raphael Bextermller Siegfried Freytag Matthias Brutigam 《Journal der Deutschen Dermatologischen Gesellschaft》2007,5(10):908-914
Background: Pimecrolimus cream 1% has proven to be well‐tolerated and effective in controlled clinical studies in patients with atopic dermatitis (AD). In a 15‐week patient self‐observation study, safety and efficacy was investigated in the daily practice. Patients and methods: 3502 patients with AD (mean age 26.2 ± 18 years, 62% female) received pimecrolimus cream 1% from 810 physicians in the German Federal Republic.The severity of the disease was assessed at baseline, two times during the 15‐week observation period and at the end of treatment.Patients recorded daily the degree of erythema and pruritus. At the end of treatment, safety and efficacy were assessed by the physician based on patient's daily records and by the patient. Results: The percentage of patients with severe or massive AD decreased from 25% to 7%, whereas the percentage of patients without or with mild symptoms increased from 9% to 55%.The efficacy of treatment was rated by physicians as good or very good in 83.5% of cases and by 79% of patients.At baseline 35% of the patients were free of flares as compared to 75% at the end of therapy. Disease control was better in patients who followed the recommended treatment algorithm for pimecrolimus cream.Tolerability was mostly rated as good or very good. Conclusion: Treatment with pimecrolimus cream 1% for patients with AD is well‐tolerated and effective in daily practice. 相似文献
6.
7.
8.
To investigate whether the secular trend for growth in Dutch children still exists, the Oosterwolde I study of 1980 was repeated in 1989. A persisting secular trend was visible for height while the z scores of body proportions show no change during the past 10 years, which suggests that there is no change in the timing of puberty. 相似文献
9.
10.
A retrospective review of post-delivery antibody records was performed at a teaching hospital and a community hospital to determine the frequency of new red cell alloantibody production and transfusion during pregnancy. If alloantibody was undetected at delivery, it was assumed that alloimmunization had not occurred. When antibody was detected, a chart review was performed to determine if the antibody was present at the beginning of the pregnancy or was newly produced during the pregnancy. A total of 17,568 pregnancies were reviewed. Antibody was detected at delivery in 948 (5.4%) cases, of which 89.5 percent (848/948) involved passive anti-D or clinically insignificant antibodies. The remaining 100 pregnancies involved clinically significant IgG antibodies. In 58 pregnancies, the antibody was detected in the first trimester, and in 42, new antibody production occurred during the pregnancy. Thus, the prevalence of new antibody production during pregnancy was 0.24 percent (95% confidence interval [CI], 0.17-0.32). Transfusion records indicated that the prevalence of transfusions during pregnancy was 0.09 percent (95% CI, 0.04-0.14). None of the women with new alloantibody formation during their pregnancies required transfusion; hence, new alloantibody production and the need for transfusion appear to be independent events. The probability of these events occurring together was 2.1 × 10(-6), or 1 in 500,000 deliveries. 相似文献